Tyrosinase 208-216 (HLA-B*07:02)
€57.50 *
Prices plus VAT plus shipping costs
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
- Order number: EP11447_1
LPWHRLFLL is a linear peptidic epitope (epitope ID38770) studied as part of Tyrosinase from Homo... more
Product information "Tyrosinase 208-216 (HLA-B*07:02)"
LPWHRLFLL is a linear peptidic epitope (epitope ID38770) studied as part of Tyrosinase from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
Available downloads:
####
| Sequence: | LPWHRLFLL | |
| Gene: | Tyr | |
| Delivery: | 2-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Purity: | 95% | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Tyrosinase | |
| Species: | Human | |
| Allele: | HLA-B*07:02 | |
| Application : | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry | |
| Indication : | AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1Molecular Weight: 1194.60 |
Dokumente - Protokolle - Downloads more
Protocols and Tips
Data sheets
Viewed